Monoclonal antibodies specific for dengue virus type 3

Area of Science:

• Immunology
• Virology
• Biotechnology

Background:

• Dengue virus poses a significant global health threat.
• Development of specific diagnostic tools and therapeutics is crucial.

Purpose of the Study:

• To generate a specific monoclonal antibody against dengue virus type 3.
• To characterize the specificity and binding properties of the developed antibody.

Main Methods:

• Hybridoma technology involving polyethylene glycol-mediated fusion.
• Screening of hybrid colonies using indirect immunofluorescent antibody technique.
• Characterization of antibody activity via hemagglutination inhibition and antigen absorption assays.

Main Results:

• 46 out of 50 hybrid colonies exhibited antibody activity against dengue-3 infected cells.
• The cloned monoclonal antibody demonstrated specific activity against dengue-3 antigen.
• No cross-reactivity was observed with dengue virus types 1, 2, and 4 antigens.
• Antibody binding was confirmed through specific absorption with dengue-3 antigen.

Conclusions:

• A specific monoclonal antibody targeting dengue virus type 3 was successfully produced.
• The antibody exhibits high specificity and can be a valuable tool for dengue-3 research and diagnostics.